Cargando…

Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial

INTRODUCTION: HIV incidence remains high among African adolescent girls and young women (AGYW), who would benefit from pre‐exposure prophylaxis (PrEP). Strategies to increase PrEP adherence and persistence need to be evaluated in African AGY, including incentives conditional on high adherence. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celum, Connie L, Gill, Katherine, Morton, Jennifer F, Stein, Gabrielle, Myers, Laura, Thomas, Katherine K, McConnell, Margaret, van der Straten, Ariane, Baeten, Jared M, Duyver, Menna, Mendel, Eve, Naidoo, Keshani, Dallimore, Jacqui, Wiesner, Lubbe, Bekker, Linda‐Gail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695999/ https://www.ncbi.nlm.nih.gov/pubmed/33247553 http://dx.doi.org/10.1002/jia2.25636

Ejemplares similares

Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence
por: Giovenco, Danielle, et al.
Publicado: (2021)

Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South Africa
por: Morton, Jennifer F., et al.
Publicado: (2020)

Response to “Oral PrEP for young African women and men”
por: Celum, Connie L, et al.
Publicado: (2016)

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
por: Donnell, Deborah, et al.
Publicado: (2014)

Rethinking HIV prevention to prepare for oral PrEP implementation for young African women
por: Celum, Connie L, et al.
Publicado: (2015)

Preparing for long‐acting PrEP delivery: building on lessons from oral PrEP
por: Celum, Connie, et al.
Publicado: (2023)

Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa
por: Ndimande-Khoza, Makhosazane Nomhle, et al.
Publicado: (2023)

Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda
por: Muwonge, Timothy R., et al.
Publicado: (2020)

Adaptation and validation of simple tools to screen and monitor for oral PrEP adherence
por: Zissette, Seth, et al.
Publicado: (2021)

PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial
por: Celum, Connie, et al.
Publicado: (2021)

Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP)
por: Li, Linying, et al.
Publicado: (2020)

Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda
por: Stalter, Randy, et al.
Publicado: (2020)

Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the “PrEP as a bridge to ART” strategy
por: Musinguzi, Nicholas, et al.
Publicado: (2020)

Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya
por: Rousseau, Elzette, et al.
Publicado: (2021)

Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa
por: Velloza, Jennifer, et al.
Publicado: (2018)

866. Adherence to F/TDF for PrEP in Dried Blood Spots and HIV Infection Rates: A Pooled Analysis of Global PrEP Studies
por: Liu, Albert, et al.
Publicado: (2021)

Association of sexual relationship power with PrEP persistence and other sexual health outcomes among adolescent and young women in Kenya and South Africa
por: Rousseau, Elzette, et al.
Publicado: (2023)

Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
por: Johnson, Leah M., et al.
Publicado: (2019)

A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa
por: Rousseau, Elzette, et al.
Publicado: (2021)

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa
por: Hosek, Sybil, et al.
Publicado: (2016)

A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial
por: Celum, Connie, et al.
Publicado: (2023)

No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda
por: Ortblad, Katrina F., et al.
Publicado: (2019)

Tailored combination prevention packages and PrEP for young key populations
por: Pettifor, Audrey, et al.
Publicado: (2015)

PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project
por: Celum, Connie L., et al.
Publicado: (2022)

The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya
por: Irungu, Elizabeth M., et al.
Publicado: (2019)

Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples
por: Nakku‐Joloba, Edith, et al.
Publicado: (2019)

Frequency of False Positive Rapid HIV Serologic Tests in African Men and Women Receiving PrEP for HIV Prevention: Implications for Programmatic Roll-Out of Biomedical Interventions
por: Ndase, Patrick, et al.
Publicado: (2015)

PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa
por: Haberer, Jessica E., et al.
Publicado: (2019)

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
por: Donnell, Deborah, et al.
Publicado: (2023)

Pharmacy delivery to expand the reach of PrEP in Africa
por: Ortblad, Katrina F, et al.
Publicado: (2020)

Response to “Being prepared to evaluate pregnancy PrEP”
por: Dettinger, Julia C, et al.
Publicado: (2019)

Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa
por: Matthews, Lynn T, et al.
Publicado: (2019)

Uptake and impact of facility‐based HIV self‐testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya
por: Wanga, Valentine, et al.
Publicado: (2020)

Effects of Polymer Blending on the Performance of a Subcutaneous Biodegradable Implant for HIV Pre-Exposure Prophylaxis (PrEP)
por: Li, Linying, et al.
Publicado: (2021)

“I know why I am taking this pill”: Young women navigation of disclosure and support for PrEP uptake and adherence in Eastern Cape Province, South Africa
por: Daniels, Joseph, et al.
Publicado: (2023)

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study
por: Cressey, Tim R., et al.
Publicado: (2017)

The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
por: Solomon, Marc M., et al.
Publicado: (2016)

What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa
por: Smith, Philip John, et al.
Publicado: (2023)

HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery
por: Celum, Connie L, et al.
Publicado: (2019)

The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b9rmo5tqdhkdgogjhq68l2j8ek